Logo

People in the News: Elaine Warburton: Jan 7, 2014

Jan 07, 2014
Premium

QuantumDx CEO Elaine Warburton will become an Officer of the Order of the British Empire, the Newcastle, UK-based molecular diagnostics firm announced recently.

Warburton cofounded QuantumDx in 2008. The British biotechnology firm is developing several point-of-care tests on a number of platforms, including a nanowire array-based biosensor. QuantumDx said that Warburton is receiving the OBE in recognition of her work with QuantumDx and other healthcare-focused companies and initiatives.

Filed under

Microarrays & Multiplexing
microarrays
QuantumDx
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.